← All indications
Aortic Aneurysm
An abnormal balloon- or sac-like dilatation in the wall of AORTA.
Subtype terms (4)
More specific conditions that are subtypes of Aortic Aneurysm in the MeSH hierarchy.
- Aortic Aneurysm, Abdominal
46 drugs (37 approved, 9 experimental)
- Aortic Aneurysm, Thoracic
11 drugs (8 approved, 3 experimental)
- Aortic Rupture
- Loeys-Dietz Syndrome
Drugs by status
Phase 4 trials (2)
Phase 3 trials (3)
Phase 2 trials (2)
Phase 1 trials (2)
Organizations
Organization Involved with Phase 4 Indications (24)
- The Medicines Company
- Octapharma
- Pfizer
- Vifor Inc.
- Husson University
- Harvard University
- Duke University
- Monash University
- Osaka University
- Palo Alto Veterans Institute for Research
- Silesian University of Medicine
- Stanford University
- Sykehuset i Vestfold HF
- University of Hull
- Yonsei University
- University of Copenhagen
- University of Turku
- The Alfred Hospital
- Sun Yat-Sen University
- Methodist Cancer Center, Houston, Texas
- Vita-Salute University of Milano. Italy
- University of Burgundy
- The University of Texas, Dallas
- Medical University of Silesia
Organization Involved with Phase 3 Indications (12)
- Merck KGaA
- Hospital do Coracao
- Regina Qu'Appelle Health Region
- University of Edinburgh
- Medical University of Vienna
- British Heart Foundation
- Brazilian Clinical Research Institute
- University of Sao Paulo
- University of Western Ontario
- Canadian Institutes of Health Research (CIHR)
- University of Franche-Comté
- 3-D Matrix Medical Technology
Organization Involved with Phase 2 Indications (23)
- CSL Behring
- Action Pharma A/S
- AstraZeneca
- Novartis
- GlaxoSmithKline
- RSPR Pharma AB
- National Institute on Aging (NIA)
- University of London
- Kaiser Permanente
- Naestved Hospital
- University of Kentucky
- University of Maryland
- University of Nebraska
- University of Southern Denmark
- University of California, San Francisco
- Uppsala University
- Vanderbilt University
- Leiden University
- University of Wisconsin
- University of Paris
- Department of Veteran Affairs
- National Institute for Health Research, United Kingdom
- Research Unit, Naestved, Region Zealand, Denmark.
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (13)
- Hospital Israelita Albert Einstein
- Institut National de la Santé Et de la Recherche Médicale, France
- Norwegian University of Science and Technology
- Onassis Cardiac Surgery Centre
- University of Michigan
- University of Ottawa
- University of Amsterdam
- Free University of Amsterdam
- Pennsylvania State University
- Washington University in St. Louis
- The Physicians' Services Incorporated Foundation
- University of Lorraine
- Albert Einstein Israelite Hospital